HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

triaquaoxohexakis(propionato)trichromium(III)

used as a nutritional supplement

Also Known As:

Cr(3)O(O2CCH2CH3)6(H2O)3; Cr(III)(3)O(O2CCH2CH3)6(H2O)3; Cr3O(O2CCH2CH3)6(H2O)3

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - triaquaoxohexakis(propionato)trichromium(III): 4

Experts

1.	Vincent, John B: 3 articles (11/2015 - 05/2004)
2.	Clodfelder, Buffie J: 2 articles (03/2005 - 05/2004)
3.	Krejpcio, Zbigniew: 1 article (05/2016)
4.	Staniek, Halina: 1 article (05/2016)
5.	Wieczorek, Daria: 1 article (05/2016)
6.	Deng, Ge: 1 article (11/2015)
7.	Dyroff, Samantha L: 1 article (11/2015)
8.	Honan, Rachel E: 1 article (11/2015)
9.	Kuykendall, M Kaitlyn: 1 article (11/2015)
10.	Rasco, Jane F: 1 article (11/2015)

Related Diseases

1.	Body Weight (Weight, Body) 05/01/2016 - "The study was carried out on 30 10-week-old female Wistar rats, which were divided into five equal groups (six animals in each): the control group and four groups of tested animals which had free access to the diet supplemented with 100, 200, 500 and 1000 mg Cr · kg(-1) (equivalent of 10, 20, 50 and 100 mg Cr · kg body weight (b.w.) · day(-1)), given as [Cr3O(O2CCH2CH3)6(H2O)3]⋅NO3, also known as Cr3, for 4 weeks. "
2.	Insulin Resistance 03/01/2005 - "Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats." 11/01/2015 - "As Cr(III) compounds have been shown to increase insulin sensitivity and decrease plasma cholesterol and triglycerides in rodent models of diabetes and insulin resistance and as colorectal cancer risk has been associated with insulin resistance and diabetes, the effects of the Cr(III) compound Cr3 ([Cr3O(O2CCH2CH3)6(H2O)3](+)) were investigated in male and female FVB/NJ mice with azoxymethane-induced colorectal cancer. " 05/01/2004 - "The cation [Cr3O(O2CCH2CH3)6(H2O)3]+ has been shown in vitro to mimic to the oligopeptide chromodulin's ability to stimulate the tyrosine kinase activity of insulin receptor and shown in healthy and type 2 diabetic model rats to increase insulin sensitivity and decrease plasma total and low-density lipoprotein cholesterol and triglycerides concentrations. "
3.	Colorectal Neoplasms (Colorectal Cancer) 11/01/2015 - "As Cr(III) compounds have been shown to increase insulin sensitivity and decrease plasma cholesterol and triglycerides in rodent models of diabetes and insulin resistance and as colorectal cancer risk has been associated with insulin resistance and diabetes, the effects of the Cr(III) compound Cr3 ([Cr3O(O2CCH2CH3)6(H2O)3](+)) were investigated in male and female FVB/NJ mice with azoxymethane-induced colorectal cancer. "

Related Drugs and Biologics

1.	Triglycerides (Triacylglycerol)
2.	Insulin Receptor
3.	Protein-Tyrosine Kinases (Tyrosine Kinase)
4.	Oligopeptides
5.	LDL Cholesterol
6.	Cholesterol
7.	Cations
8.	Azoxymethane

Related Therapies and Procedures

1.	Oral Administration